• Artivion Inc AORT.N reported a quarterly adjusted loss of 39 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -10 cents. The mean expectation of six analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -15 cents to 2 cents per share.

• Revenue rose 3.9% to $97.31 million from a year ago; analysts expected $100.82 million.

• Artivion Inc's reported EPS for the quarter was a loss of 39 cents​.

• The company reported a quarterly loss of $16.48 million.

• Artivion Inc shares had fallen by 1.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.7% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Artivion Inc is $33.00

This summary was machine generated from LSEG data February 24 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)